Detalhe da pesquisa
1.
Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study.
Acta Otorrinolaringol Esp (Engl Ed)
; 73(2): 82-88, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35397828
2.
Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study.
Acta Otorrinolaringol Esp (Engl Ed)
; 2021 Jun 18.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-34154795
3.
[Role of the ears, nose and throat specialist in the diagnosis and follow up of patients with primary vasculitidies]. / Papel del otorrinolaringólogo en el diagnóstico y seguimiento de pacientes con vasculitis primarias.
Reumatol Clin
; 7 Suppl 3: S7-11, 2011 Dec.
Artigo
em Espanhol
| MEDLINE | ID: mdl-22115871